Jump to content

SBK3

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by FrescoBot (talk | contribs) at 23:59, 3 November 2020 (Bot: link syntax). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

SBK3
Identifiers
AliasesSBK3, SGK110, SH3 domain binding kinase family member 3
External IDsMGI: 2685924; HomoloGene: 82595; GeneCards: SBK3; OMA:SBK3 - orthologs
Orthologs
SpeciesHumanMouse
Entrez

100130827

381835

Ensembl

ENSG00000231274

ENSMUSG00000085272

UniProt

P0C264

P0C5K0

RefSeq (mRNA)

NM_001199824

NM_001200041

RefSeq (protein)

NP_001186753

NP_001186970

Location (UCSC)Chr 19: 55.54 – 55.55 MbChr 7: 4.97 – 4.97 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

SH3 Domain Binding Kinase Family Member 3 is an enzyme that in humans is encoded by the SBK3 gene (also known as SGK110).[5] SBK3 is a member of the serine/threonine protein kinase family.[6] The SBK3 protein is known to exhibit transferase activity, especially phosphotransferase activity, and tyrosine kinase activity.[7] It is well-conserved throughout mammalian organisms and has two paralogs: SBK1 and SBK2.[8]

Gene

SBK3 is found on the minus strand of chromosome 19 in humans: 19q13.42.[9] Its reference isoform consists of 4,985 bases. Nearby genes include SBK2, a paralog to SBK3, as well as SSC5D, ZNF579, and FIZ1.[10]

Transcripts

SBK3 has five exons; however, only four are included in the final mRNA transcript.[11] SBK3 is found to have one isoform outside of its typical transcript. The reference isoform does not include exon 2 and isoform X1 does not include exon 1.[12]

Transcript Accession Number Protein Length
Reference NM_001199824 359 aa
Isoform X1 XM_011526298 384 aa

Protein

General properties

SBK3's reference protein has a predicted molecular mass of 38.5 kDa and isoelectric point of 4.71 pI.[13] SBK3 has a significantly higher presence of proline amino acids than most proteins, which aligns with its proline-rich compositional bias that spans residues 189-278.[14] The exact function of this proline-rich region in SBK3 is yet to be determined; however, prior research states that it's the region in which the SH3 domain of interacting proteins binds to SBK3.[15]

Primary sequence

As previously stated, SBK3's reference protein is made up of 359 amino acids. The polypeptide chain that results from the translation of SBK3 into the SBK3 protein is shown below. A non-canonical polyadenylation signal ‘TATAAA’ is found 622 bases downstream from the stop codon.[16]

Conceptual translation of the SBK3 reference protein. Highly conserved amino acids throughout orthologs are represented in bold. Annotations highlight its polypeptide sequence, exon-exon junctions, transcriptional/translational element locations, domains, motifs, and post-translational modifications.

Domains

SBK3 has a large conserved catalytic domain specific to the protein kinase superfamily.[17] Nineteen ATP-binding sites found in SBK3’s paralog, SBK1, are all conserved in SBK3. The tyrosine motif exists in SBK3 (residues 44-233) and is found to overlap the conserved protein kinase superfamily domain (residues 49-208).[18] SBK3's active site (ACT) is predicted to span residues 159-171.[19] A cross-program analysis revealed a predicted transmembrane domain (TMD) approximately spanning residues 224-240.[20][21][22][23][24][25][26] A SUMO-interacting motif (SIM) is predicted to span residues 298-302.[27]

Domains
Illustration of SBK3's predicted domains, motifs, and post-translational modifications.
TMD
Visual depiction of SBK3's predicted transmembrane domain created through Protter.[28]

Secondary structure

Cross-program analysis results for SBK3's secondary structure. Alpha helices are red and beta sheets are blue.

A cross-program analysis predicted SBK3's secondary structure to consist of eight alpha helices and two beta sheets.[29][30][31][32][33]

The predicted tertiary structure for SBK3 created through I-TASSER.

Tertiary structure

SBK3's predicted tertiary structure is shown to have many alpha-helices and few beta-sheets, thereby aligning with previous secondary structure predictions.[34] Homologous proteins were analyzed to identify structural similarities. According to PHYRE2, SBK3's sequence is similar to that of the F chain of the α subunit of IκB kinase (73% query cover, 24% identical) which is involved in the upstream NF-κB signal transduction cascade.[35] According to SWISS-MODEL, SBK3's sequence is 30% similar to mitogen-activated protein kinase 8 (MAPK8).[36]

Ligand binding

The 1JC ligand is predicted to interact with the SBK3 protein (97% confidence).[37] This ligand is functionally annotated to bind to a receptor tyrosine kinase called the hepatocyte growth factor receptor.[38]

Regulation

Gene level regulation

Enhancer initiated transcription

The location of SBK3's promoter and associated enhancer align with the concept of enhancer initiated transcription because their sequences, as found on chromosome 19, overlap. Recent studies have shown that enhancers can sometimes initiate transcription; however, the functional role of transcription initiation by enhancers is not yet defined.[39]

Element Identifier Start Location Stop Location Length
Promoter GXP_8988905 55544824 55546120 1296 bp
Enhancer GH19J055544 55544907 55551056 6149 bp

Tissue expression

Overall, SBK3 has low expression as it is expressed at only 4.6% of the average human gene.[40] SBK3's highest levels of expression are in human cardiac muscle tissue, but it is also found to be expressed in skeletal muscle tissue.[41][42] During human fetal development, expression is the highest within the lung at 17 weeks.[43] In mice, SBK3 is annotated as having biased expression primarily in adult heart tissue, which is followed by adult lung tissue.[44] However, in the mouse embryo, there is no evidence of biased expression.[45] In pig brains, the retina was shown to have the highest level of SBK3 expression.[46]

Conditional expression

A novel conditional nebulin knockout mouse model revealed an increase in SBK3 expression in the quadricep and soleus muscles.[47] The mice in this study were born with high nebulin levels in their skeletal muscle but nebulin expression rapidly fell within weeks after birth. This study observed that knockout mice that survived to adulthood experienced fiber-type switching towards oxidative types. Consequently, SBK3 expression was found to increase in the quadricep and soleus muscles of nebulin conditional knockout mice.

Transcript level regulation

miRNA targeting

In its 3'UTR, SBK3 is predicted to be targeted by four miRNAs: hsa-miR-637, hsa-miR-6077, hsa-miR-6760-5p, and hsa-miR-1291.[48] All four miRNAs are conserved throughout primates and are identified to bind to stem-loop structures found within the 3' UTR.[49]

Protein level regulation

Post-translational modifications

Image depicting the locations in which SBK3 is predicted to undergo phosphorylation, O-GlcNAc, SUMOylation, and C-mannosylation.

SBK3 has 29 proposed phosphorylation sites at various serine, threonine, and tyrosine residues.[50] O-GlcNAc is predicted to occur at five threonines and one serine.[51] SUMOylation was predicted to occur at two lysine residues: K165 and K347; a SUMO-interacting motif was found between residues 298-302.[52] SBK3 is also predicted undergo C-mannosylation at a singular tryptophan residue: W258.[53]

Subcellular localization

Through the use of antibodies, SBK3 has been observed to localize to the mitochondria.[54] PSORT's k-NN prediction determined that SBK3 was 39.1% likely to localize to the mitochondria and 21.7% likely to localize to the cytoplasm.[55] The Reinhardt method predicted SBK3's localization to by cytoplasmic with a reliability score of 89.[56] No signal peptide has been found in SBK3.[57] Further analysis of SBK3's behavior in the cell is required to fully understand its subcellular localization.

Homology/evolution

Paralogs

As previously stated, SBK3 has two paralogs: SBK1 and SBK2.[58]

Gene Accession Number Sequence Identity (%)
SBK1 NP_001019572.1 41.98
SBK2 NP_001357025.1 38.87

Orthologs

A total of 141 organisms are found to have orthologs with the SBK3 gene, all of which are jawed vertebrates. Of these 141 orthologs, 121 of them are mammals. SBK3 is not found in amphibians.[59]

Species Common Name Accession Number Length Sequence Identity (%) Sequence Similarity (%) Date of Divergence
Homo sapiens Human NP_001186753.1 359 aa 100 100 0 MYA
Macaca mulatta Rhesus Monkey XP_014980441.2 358 aa 96.7 98.6 29.44 MYA
Gopherus evgoodei Tortoise XP_030400222 387 aa 45.5 58.5 312 MYA
Haliaeetus leucocephalus Bald Eagle XP_010568394 353 aa 42.5 54.7 312 MYA
Callorhinchus milii Ghostshark XP_007887001 383 aa 31.2 43.6 473 MYA

Phylogeny

SBK3 diverged from cartilaginous fishes around 400 years ago, birds and reptiles around 300 million years ago, non-primate mammals around 90 million years ago. Divergence from primates last occurred around nine million years ago.[60]

Function

SBK3 is statistically predicted to be involved in sarcomere organization, regulation of muscle relaxation, cardiac myofibril assembly, and regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ions.[61] However, the function of SBK3 has yet to be well understood by the scientific community.

Interacting proteins

Transcription factor binding sites

SBK3's promoter region was analyzed to identify predicted transcription factor binding sites (TFBS) that had high matrix similarity scores, close proximity to the transcription start site (TSS), high conservation throughout primates, and/or are a TATA-binding protein (TBP). Conserved matrix families of interest include KLFS and mammalian transcriptional repressor (RBPF) as they both pertain to cardiac differentiation and function.[62][63][64]

Predicted TFBS on SBK3's promoter with high matrix similarity scores, close proximity to the TSS, high conservation throughout primates, and/or are a TBP.

Protein-protein interactions

According to STRING, SBK3 interacts with FAM86B1, TBCK, POMK, DNPEP, TEX14, PKDCC, and TM6SF1.[65] Many of these proteins are associated with a form of kinase activity. According to Mentha, SBK3 interacts with SMAD3, MBD3L2, Q494R0, SNRNP35, A8MTQ0, AIMP2, DMAP1, EXOSC2, TNNT1, GATAD2B, and Q8WUT1.[66] SMAD3 is a receptor-regulated subtype of SMAD, which is shown to have a highly conserved TFBS in SBK3 with a high matrix similarity score.

Mentha
Mentha's predicted protein-protein interactions for SBK3 (P0C264).
STRING
STRING's predicted protein-protein interactions for SBK3.

Clinical significance

SBK3 has been shown to be enriched in hemostasis and signal transduction pathways.[67] Additionally, a GWAS study highlighted a significant association between SBK3 and unspecified psychiatric, cognitive, and behavioral traits.[68] In lupus kidney biopsies, SBK3 was shown to have a negative correlation with the expression of CD3 and CD4 T-cell receptors.[69] In a study comparing primary tumors and metastatic tumors from the kidney, this gene was found to have at least a two-fold increase in expression in metastasic tumors.[70] A pharmacological profiling study identified SBK3 as an inhibitor of fostamanib, an orphan drug for rheumatoid arthritis and immune thrombocytopenic purpura.[71]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000231274 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000085272 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ "SBK3 Gene". Gene Cards.
  6. ^ "SBK3". NCBI Gene. NCBI.
  7. ^ "SBK3 Gene". Gene Cards. Retrieved 27 April 2020.
  8. ^ "SBK3". NCBI Gene. NCBI. Retrieved 27 April 2020.
  9. ^ "SBK3 Gene". Gene Cards. Retrieved 27 April 2020.
  10. ^ "SBK3". NCBI Gene. NCBI.
  11. ^ "SBK3 Gene". Gene Cards.
  12. ^ "SBK3". NCBI Gene. NCBI.
  13. ^ "Compute pI/Mw". ExPASy.
  14. ^ "SAPS". EMBL-EBI.
  15. ^ Pollard T, Earnshaw W, Lippincott-Schwartz J, Johnson G (30 November 2016). Cell Biology (3rd ed.). Elsevier.
  16. ^ Kalkatawi M, Rangkuti F, Schramm M, Jankovic BR, Kamau A, Chowdhary R, et al. (June 2013). "Dragon PolyA Spotter: predictor of poly(A) motifs within human genomic DNA sequences". Bioinformatics. 29 (11): 1484. doi:10.1093/bioinformatics/btt161. PMID 23616439.
  17. ^ "SBK3". NCBI Gene. NCBI.
  18. ^ "MOTIF Search". MOTIF Search.
  19. ^ "Motif Scan". Motif Scan. ExPASy.
  20. ^ "Phobius". Phobius.
  21. ^ "Prediction of Transmembrane Regions and Orientation". TMpred. ExPASy.
  22. ^ "Phyre2". Phyre2.
  23. ^ "PSIPRED". PSIPRED. UCL Department of Computer Science: Bioinformatics Group.
  24. ^ "Protein Subcellular Localization Prediction Tool". PSORT. GenScript.
  25. ^ Mitaku S, Hirokawa T. "SOSUI". SOSUI.
  26. ^ Jones D. "SACS MEMSAT2 Transmembrane Prediction Page". SACS MEMSTAT2.
  27. ^ "Prediction of SUMOylation Sites & SUMO-binding Motifs". GPS-SUMO. GPS.
  28. ^ "Protter". Protter.
  29. ^ "Phyre2". Phyre2.
  30. ^ "Prabi". Prabi.
  31. ^ Ashok, Kumar. "Chou and Fasman Secondary Structure Prediction server". CFSSP.
  32. ^ "Jpred4". Jpred4.
  33. ^ "Ali2D". MPI Bioinformatics Toolkit.
  34. ^ "I-TASSER". I-TASSER. Zhang Lab. Retrieved 21 April 2020.
  35. ^ "Phyre2". Phyre2.
  36. ^ "SWISS-MODEL". SWISS-MODEL. ExPASy.
  37. ^ "I-TASSER". I-TASSER. Zhang Lab. Retrieved 21 April 2020.
  38. ^ "BioLip". Ligand-Protein Binding Database. Zhang Lab.
  39. ^ Tippens ND, Vihervaara A, Lis JT (January 2018). "Enhancer transcription: what, where, when, and why?". Genes & Development. 32 (1): 1–3. doi:10.1101/gad.311605.118. PMC 5828389. PMID 29440223.
  40. ^ "LOC100130827". AceView. NCBI.
  41. ^ "SBK3". NCBI Gene. NCBI. Retrieved 27 April 2020.
  42. ^ "Cell Atlas". The Human Protein Atlas.
  43. ^ "SBK3". NCBI Gene. NCBI.
  44. ^ "SBK3". NCBI Gene. NCBI.
  45. ^ "Gene Paint". Gene Paint.
  46. ^ "Cell Atlas". The Human Protein Atlas.
  47. ^ Li F, Buck D, De Winter J, Kolb J, Meng H, Birch C, et al. (September 2015). "Nebulin deficiency in adult muscle causes sarcomere defects and muscle-type-dependent changes in trophicity: novel insights in nemaline myopathy". Human Molecular Genetics. 24 (18): 5219–33. doi:10.1093/hmg/ddv243. PMC 4550825. PMID 26123491.
  48. ^ "miRDB". miRDB.
  49. ^ "unafold". unafold.
  50. ^ "NetPhos 3.1 Server". NetPhos 3.1 Server. DTU Bioinformatics.
  51. ^ "YinOYang 1.2 Server". YinOYang 1.2 Server. DTU Bioinformatics.
  52. ^ "Prediction of SUMOylation Sites & SUMO-binding Motifs". GPS-SUMO. GPS.
  53. ^ "NetCGlyc 1.0 Server". NetCGlyc 1.0 Server. DTU Bioinformatics.
  54. ^ "Cell Atlas". The Human Protein Atlas.
  55. ^ "PSORT II Prediction". PSORT II Prediction.
  56. ^ "PSORT II Prediction".
  57. ^ "Phobius". Phobius.
  58. ^ "SBK3". NCBI Gene. NCBI. Retrieved 27 April 2020.
  59. ^ "SBK3". NCBI Gene. NCBI. Retrieved 27 April 2020.
  60. ^ "TimeTree". TimeTree.
  61. ^ "SBK3". ARCHS4. Retrieved 27 April 2020.
  62. ^ "ElDorado". Genomatix. Retrieved 27 March 2020.
  63. ^ Pollak NM, Hoffman M, Goldberg IJ, Drosatos K (February 2018). "Krüppel-like factors: Crippling and un-crippling metabolic pathways". JACC. Basic to Translational Science. 3 (1): 132–156. doi:10.1016/j.jacbts.2017.09.001. PMC 5985828. PMID 29876529.
  64. ^ Desjardins CA, Naya FJ (June 2017). "Antagonistic regulation of cell-cycle and differentiation gene programs in neonatal cardiomyocytes by homologous MEF2 transcription factors". The Journal of Biological Chemistry. 292 (25): 10613–10629. doi:10.1074/jbc.M117.776153. PMC 5481567. PMID 28473466.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  65. ^ "STRING". STRING.
  66. ^ "Mentha". Mentha.
  67. ^ Wetherill L, Lai D, Johnson EC, Anokhin A, Bauer L, Bucholz KK, et al. (July 2019). "Genome-wide association study identifies loci associated with liability to alcohol and drug dependence that is associated with variability in reward-related ventral striatum activity in African- and European-Americans". Genes, Brain, and Behavior. 18 (6): e12580. doi:10.1111/gbb.12580. PMC 6726116. PMID 31099175.
  68. ^ Wetherill, L., Lai, D., Johnson, E. C., Anokhin, A., Bauer, L., Bucholz, K. K., ... & Kramer, J. (2019). Genome‐wide association study identifies loci associated with liability to alcohol and drug dependence that is associated with variability in reward‐related ventral striatum activity in African‐and European‐Americans. Genes, Brain and Behavior, 18(6), e12580.
  69. ^ Pamfil C, Makowska Z, De Groof A, Tilman G, Babaei S, Galant C, et al. (December 2018). "Intrarenal activation of adaptive immune effectors is associated with tubular damage and impaired renal function in lupus nephritis". Annals of the Rheumatic Diseases. 77 (12): 1782–1789. doi:10.1136/annrheumdis-2018-213485. PMC 6241616. PMID 30065042.
  70. ^ Zhao, Amy; Guru, Arjun; Guru, Sonpavde; Yang, Eddy; Li, Yufeng (2015). "Gene expression in primary and metastatic kidney cancer to discover drivers of metastasis and targets for drug development". Journal for ImmunoTherapy of Cancer. 3. doi:10.1186/2051-1426-3-S2-P215.
  71. ^ Rolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, et al. (October 2015). "In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib". Pharmacology Research & Perspectives. 3 (5): e00175. doi:10.1002/prp2.175. PMC 4618646. PMID 26516587.
Retrieved from "https://en.wikipedia.org/w/index.php?title=SBK3&oldid=986956575"